ProMIS Neurosciences, Inc. (PMN)
24.60
+1.81
(+7.94%)
USD |
NASDAQ |
Mar 03, 16:00
24.11
-0.49
(-1.99%)
After-Hours: 20:00
ProMIS Neurosciences Total Assets (Quarterly) : 21.46M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 10.82M |
| Aurinia Pharmaceuticals, Inc. | 770.59M |
| Edesa Biotech, Inc. | 14.71M |
| Lexaria Bioscience Corp. | 6.051M |
| Xenon Pharmaceuticals, Inc. | 981.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.27M |
| Shareholders Equity (Quarterly) | 9.187M |
| Current Ratio | 1.757 |